Venture investments in life science companies fall in 3Q
San Diego Union-Tribune Friday 4th November, 2011
Venture capital investment in U.S. life sciences and biotechnology companies in the third quarter fell 18 percent to $1.8 billion, its lowest level in more than two and a half years, according to a report from PricewaterhouseCoopers. "VCs are saying that challenges in the regulatory environment for life sciences companies are prompting them to loo...

Comments
No comments yet for this story